MOST RECENT AWARDS
2017 & 2018
Worldwide was recognized by Life Science Leader’s 2018 CRO Leadership Awards. This program recognized performance in five core categories (capabilities, compatibility, expertise, quality and reliability) across three groups – “Big Pharma,” “Small Pharma,” and “Overall.”
Worldwide Clinical Trials has been announced as a finalist for a second year in the 2017 “Best Contract Research Organization – Full Service Providers” category of the Scrip awards.
Neal Cutler, M.D., Founder and Chief Executive Officer at Worldwide, was named as the “Best CEO in the CRO Industry” by European CEO Awards 2017. Since first creating Worldwide 30 years ago, Dr. Cutler has led with a steadfast commitment to the medicine and science of clinical research.
Michael F. Murphy, M.D., Ph.D., Chief Medical and Scientific Officer at Worldwide, received the Clinical Research & Excellence (CARE) 2017 Lifetime Achievement Award. This prestigious award recognizes Dr. Murphy’s exceptional contributions and his consistent history of service and dedication to the clinical research industry throughout his career.
Worldwide was recognized by Life Science Leader’s 2017 CRO Leadership Awards. This program recognized performance in five core categories (capabilities, compatibility, expertise, quality and reliability) across three groups – “Big Pharma,” “Small Pharma,” and “Overall.” Worldwide came away a winner in 12 of the 15 categories.
Worldwide and its clinical research partner since 2010, Bellerophon Therapeutics, have been honored as finalists in the 2017 Clinical & Research Excellence Awards for “Clinical Partnership of the Year.” Worldwide currently supports Bellerophon with its two-year clinical development program for INOpulse, providing a broad range of contract research services.
ALL AWARDS
2018 & PRIOR
Worldwide was recognized by Life Science Leader’s 2018 CRO Leadership Awards. This program recognized performance in five core categories (capabilities, compatibility, expertise, quality and reliability) across three groups – “Big Pharma,” “Small Pharma,” and “Overall.”
Worldwide Clinical Trials has been announced as a finalist for a second year in the 2017 “Best Contract Research Organization – Full Service Providers” category of the Scrip awards.
Neal Cutler, M.D., Founder and Chief Executive Officer at Worldwide, was named as the “Best CEO in the CRO Industry” by European CEO Awards 2017. Since first creating Worldwide 30 years ago, Dr. Cutler has led with a steadfast commitment to the medicine and science of clinical research.
Michael F. Murphy, M.D., Ph.D., Chief Medical and Scientific Officer at Worldwide, received the Clinical Research & Excellence (CARE) 2017 Lifetime Achievement Award. This prestigious award recognizes Dr. Murphy’s exceptional contributions and his consistent history of service and dedication to the clinical research industry throughout his career.
Worldwide was recognized by Life Science Leader’s 2017 CRO Leadership Awards. This program recognized performance in five core categories (capabilities, compatibility, expertise, quality and reliability) across three groups – “Big Pharma,” “Small Pharma,” and “Overall.” Worldwide came away a winner in 12 of the 15 categories.
Worldwide and its clinical research partner since 2010, Bellerophon Therapeutics, have been honored as finalists in the 2017 Clinical & Research Excellence Awards for “Clinical Partnership of the Year.” Worldwide currently supports Bellerophon with its two-year clinical development program for INOpulse, providing a broad range of contract research services.
Worldwide was ranked as the industry’s #1 provider of Overall Contract Research in the “2017 Nice Insight Preclinical and Clinical Contract Research Survey.” The survey examined market perceptions of clinical research organizations (CROs) using data collected from 608 outsourcing-facing pharmaceutical and biotechnology executives.
Worldwide Clinical Trials was honored as a finalist in the prestigious 2016 Scrip Awards. Selected in the “Best Contract Research Organization – Full Service Providers” category, Worldwide was chosen by a distinguished panel of life science industry experts, and was included as a finalist among six leading, global CROs.
Corporate LiveWire recognized Worldwide as “Best in Neuroscience Therapeutics” in its 2016 Healthcare & Life Sciences Awards, which recognize the pinnacle of business achievement and organizations that have made a difference in patient lives. The awards celebrate the most innovative and successful projects around the world over the previous 12 months.
Worldwide was recognized by Life Science Leader’s 2016 CRO Leadership Awards. This program recognized performance in five core categories (capabilities, compatibility, expertise, quality and reliability) across three groups – “Big Pharma,” “Small Pharma,” and “Overall.” Worldwide came away a winner in 13 of the 15 categories.
Worldwide Clinical Trials was honored as a leader in by the 2015 CRO Leadership Awards, sponsored by Life Science Leader. Winning CROs were rated in the top 10 percent in their respective categories. Worldwide was named a winner in Quality, Productivity, and Innovation by the Emerging Biotech category of voters.
Worldwide Clinical Trials was recognized as a leader in Quality, Productivity and Regulatory performance by the 2014 CRO Leadership Awards, sponsored by Life Science Leader. Worldwide was named a winner in three of the five available categories by both the Biotech and Emerging Biotech categories of voters.
